- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Study of ovarian cancer CTCs using Parsortix
- New commercial agreement with large pharma
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
More ▼
Key statistics
As of last trade, Angle PLC (AGL:LSE) traded at 21.50, 137.13% above the 52 week low of 9.07 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 22.50 |
---|---|
High | 23.00 |
Low | 22.50 |
Bid | 21.00 |
Offer | 21.50 |
Previous close | 22.50 |
Average volume | 3.72m |
---|---|
Shares outstanding | 260.58m |
Free float | 232.60m |
P/E (TTM) | -- |
Market cap | 58.63m GBP |
EPS (TTM) | -0.086 GBP |
Data delayed at least 20 minutes, as of May 17 2024 15:28 BST.
More ▼